| dc.contributor.author | C Mutai, EK Mibei, JM Etabalé, W Oyieko, GN Magak | |
| dc.date.accessioned | 2022-10-05T15:51:14Z | |
| dc.date.available | 2022-10-05T15:51:14Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5357 | |
| dc.description | The article can be accessed in full via:https://www.ajol.info/index.php/eamj/article/view/230268 | en_US |
| dc.description.abstract | The potential roles of inflammatory makers in prostate cancer are subjects of intense examination and Interleukin-6 receptor (IL-6R) is key in these processes. Expression of interleukin-6 Receptor (IL-6R) has not been evaluated as a prognostic biomarker in grading of prostate cancer (Pca) in our population, yet inflammation is not uncommon. The current study therefore evaluated their expression in prostatic acinar adeno-carcinoma (PAA) patients of different Gleason grades. | en_US |
| dc.title | Expression of IL-6 receptor correlates with Gleason grade for patients with prostatic acinar adenocarcinoma in Kisumu Specialist Hospital in Kisumu County, Western Kenya | en_US |
| dc.type | Article | en_US |
